ANI Pharmaceuticals, Inc. (ANIP) News Headlines

▮ More

Date

Headline

5/15/2023 7:28:14 AM ANI Pharma Says FDA Approves Methsuximide Capsules, Alendronate Sodium Oral Solution

5/15/2023 6:56:33 AM ANI Announces FDA Approval Of Methsuximide Capsules USP, 300 Mg And Alendronate Sodium Oral Solution 70 Mg (base)/75 ML

5/12/2023 9:53:52 AM ANI Pharmaceuticals Drops 10% After Pricing Share Offering

5/12/2023 7:15:19 AM Pre-market Movers: DRMA, BLBD, SURG, INCR, TISI…

5/8/2023 10:28:15 AM ANI Pharmaceuticals Jumps On Upbeat Results, Increased Outlook Above View

5/8/2023 7:05:33 AM ANI Pharmaceuticals, Inc. Q1 Earnings Summary

5/8/2023 6:52:51 AM ANI Pharma Q1 GAAP EPS $0.06; Adj EPS $1.17

4/24/2023 7:03:09 AM ANI Pharma: FDA Approves ANDA For Nitrofurantoin Oral Suspension USP

4/24/2023 6:55:26 AM ANI Pharma Gets FDA Approval For ANDA For Nitrofurantoin Oral Suspension USP, 25 Mg/5 Ml

4/4/2023 7:03:16 AM ANI Pharma: FDA Approves ANDA For Colestipol Hydrochloride Tablets USP

4/4/2023 6:53:33 AM ANI Pharma Announces FDA Approval Of Colestipol Hydrochloride Tablets USP, 1 G

3/9/2023 7:30:00 AM ANI Pharmaceuticals Q4 22 Earnings Conference Call At 8:30 AM ET

3/9/2023 7:19:30 AM ANI Pharma Guides FY23 Adj. EPS Below Estimates, But Revenues Above - Update

3/9/2023 7:01:37 AM ANI Pharma Q4 Adj EPS $0.76 Vs $0.06 Prior Year

3/9/2023 6:58:02 AM ANI Pharmaceuticals, Inc. Q4 Earnings Summary

11/28/2022 7:07:49 AM ANI Pharma: FDA Approves ANDA For Fluoxetine Oral Solution

11/28/2022 6:58:16 AM ANI Pharma Receives FDA Approval For ANDA For Fluoxetine Oral Solution, USP 20 Mg/5 ML

11/16/2022 7:03:20 AM ANI Pharma Announces FDA Approval Of Trimethoprim Tablets - Quick Facts

11/16/2022 6:55:32 AM ANI Pharma Gets FDA Approval For ANDA For Trimethoprim Tablets USP, 100 Mg

11/9/2022 7:00:09 AM ANI Pharmaceuticals Q3 22 Earnings Conference Call At 8:00 AM ET

Ani Pharmaceuticals, Inc. (ANIP)